US 11147801
Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors
granted A61KA61K31/4192A61K31/454
Quick answer
US patent 11147801 (Methods of use for trisubstituted benzotriazole derivatives as dihydroorotate oxygenase inhibitors) held by Aurigene Discovery Technologies Limited expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aurigene Discovery Technologies Limited
- Grant date
- Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/4192, A61K31/454, A61K31/496, A61K31/5377